Literature DB >> 28149152

Lenalidomide Induced Late-Onset Acute Respiratory Distress Syndrome.

Adem Karaman1, Mevlana Omeroglu2, Mucahit Emet2, Bugra Kerget3, Irmak Durur Subasi1, Fatih Alper1.   

Abstract

A 77-year-old man with multiple myeloma (MM) presented with shortness of breath to the emergency department. He also had history of chronic obstructive pulmonary disease, chronic pulmonary embolism and nephrectomy due to malignancy 10 years ago. He had been treated for 9 months with lenalidomide because of MM. He diagnosed with adult respiratory distress syndrome due to lenalidomide. We aimed to demonstrate late onset and destructive effects of lenalidomide on the lungs.

Entities:  

Keywords:  Lenalidomide; dyspnea; pulmonary toxicity; side effect

Year:  2016        PMID: 28149152      PMCID: PMC5268609          DOI: 10.5152/eurasianjmed.2015.0150

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  4 in total

Review 1.  Acute inhalation injury.

Authors:  Metin Gorguner; Metin Akgun
Journal:  Eurasian J Med       Date:  2010-04

2.  Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.

Authors:  Daniel Weiss; Robert Knight; Simon Zhou; Maria Palmisano; Nianhang Chen
Journal:  Clin Drug Investig       Date:  2015-07       Impact factor: 2.859

Review 3.  Pulmonary toxicity associated with the use of lenalidomide: case report of late-onset acute respiratory distress syndrome and literature review.

Authors:  J Mankikian; B Lioger; E Diot; P D'Halluin; S Lissandre; S Marchand Adam; E Mercier; F Beau Salinas
Journal:  Heart Lung       Date:  2013-12-19       Impact factor: 2.210

4.  Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens.

Authors:  Tina Bagratuni; Efstathios Kastritis; Marianna Politou; Maria Roussou; Efthimios Kostouros; Maria Gavriatopoulou; Evangelos Eleutherakis-Papaiakovou; Nikolaos Kanelias; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2013-07-24       Impact factor: 10.047

  4 in total
  1 in total

Review 1.  Current Pharmacological Approach to ARDS: The Place of Bosentan.

Authors:  Omer Araz
Journal:  Eurasian J Med       Date:  2020-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.